MaaT Pharma Provides Third Quarter 2023 Business Update and Reports Financial Results Independent Data Safety…
MaaT PharmaNovember 9, 2023
MaaT Pharma Announces Two Poster Presentations for MaaT013 and MaaT033 at the Upcoming ASH Conference…
MaaT PharmaNovember 2, 2023
MaaT Pharma to Present Preclinical Data at SITC on MaaT034, an Artificial Intelligence-Generated Product Aimed…
MaaT PharmaOctober 31, 2023
MaaT Pharma Announces Positive Outcome Following DSMB Review Reinforcing Confidence in Phase 3 On-Going Trial…
MaaT PharmaOctober 26, 2023
MaaT Pharma Announces Poster Presentations at the 38th Annual Meeting of the Society for Immunotherapy…
MaaT PharmaSeptember 27, 2023
MaaT Pharma and Skyepharma Complete Construction of Europe's Largest Manufacturing Facility for Microbiome Ecosystem Therapies…
MaaT PharmaSeptember 12, 2023
